BSEBoard Meeting29 Sept 2026 · 29 Sept 2026, 04:22 pm

Outcome of the board meeting for the board approves the Preferential Allotment

Bharat Parenterals Ltd · 541096

✦ AI SummaryFundraise

Bharat Parenterals Ltd has announced the outcome of its board meeting, where it approved the preferential allotment of up to 9,12,759 equity shares at Rs. 1522.85 per share for an aggregate consideration of Rs. 138,99,95,043.15. The company will convene an EGM on October 23, 2026, to seek shareholder approval for the preferential issue.

Analysis Scores

Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk4/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bharat Parenterals Ltd - 541096 - Board Meeting Outcome for Outcome Of Board Meeting For The Board Approves The Preferential Issue.

Attachments (1)

📄

f6d9abb7-7050-4b1a-9725-aa4ea17421fb.pdf

pdf

Download →
View document text
Date: September 29, 2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai –400001 Scrip Code: 541096 Sub: Outcome of Board Meeting – Board approves preferential allotment Ref: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) We wish to inform you that the Board of Directors of the Company at their meeting held today, have inter alia considered and approved the following: 1. Issuance of up to 9,12,759 (Nine Lakhs Twelve Thousand Seven Hundred and Fifty-Nine Only) equity shares of face value Rs. 10/- each fully paid up of the Company, through preferential allotment, in compliance with applicable provisions of the Companies Act, 2013 and Chapter V of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, at a price of Rs. 1522.85 (One Thousand Five Hundred Twenty-Two Rupees and Eighty-Five Paise Only) per equity share for an aggregate consideration of Rs. 138,99,95,043.15/- (One Hundred Thirty-Eight Crore Ninety-Nine Lakh Ninety-Five Thousand Forty-Three Rupees and Fifteen Paisa Only), to few Investors (Non-Promoters), as detailed in Annexure 1A, for cash consideration, subject to the approval of the shareholders of the Company and other regulatory/statutory approvals as applicable. Additional details pursuant to Regulation 30 of the Listing Regulations is attached as Annexure-1. 2. Investment in Subsidiaries – For undertaking investments in or providing loans to the subsidiaries of the Company for the purposes of development of existing and new projects, either in the form of equity / quasi equity / unsecured loan: 3. Convening of an Extraordinary general meeting on Friday, October 23, 2026 at 11:30 A.M through video conferencing or other audio-visual means, to seek necessary approval of the shareholders of the Company, for the Preferential Issue. The meeting of the Board of Directors commenced at 03:00 P.M. at the registered office and concluded at 04:00 P.M. This is for your information and records. Thanking You. For Bharat Parenterals Limited Sharmin Soni Company Secretary & Compliance Officer ICSI Membership Number: A-75694 Encls. As above Annexure-1 Additional details as required under Regulation 30 and other relevant provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Issuance of Equity Shares under Preferential Allotment Sr. Particulars Remarks a) Type of Securities proposed to be Equity Shares of Face value of Rs. 10/- each of issued (viz., equity shares, the Company convertibles etc.) b) Type of Issuance Preferential Allotment for cash consideration (viz., further public offering, rights issue, depository receipts (ADR/GDR), qualified institutions placement, preferential allotment etc.) c) Total number of securities proposed 9,12,759 Equity Shares of Rs. 10/- each at an to be issued or issue price of Rs.1522.85/- per equity share, for an aggregate consideration of Rs. the total amount for which the 138,99,95,043.15/- (One Hundred Thirty-Eight securities will be issued Crore Ninety-Nine Lakh Ninety-Five Thousand (approximately) Forty-Three Rupees and Paisa Fifteen Only) d) In case of preferential issue, the listed entity shall disclose the following additional details to the stock exchange(s): ii. Names of the Investors (ii.a) Post allotment of securities, outcome Attached as Annexure 1A of the subscription, issue/allotted price 15 (Fifteen) (ii.b) Number of investors (iii) in case of convertibles: Not Applicable intimation on conversion of securities or on lapse of the tenure of the instrument Annexure 1A Name of Investors, Post allotment of securities, outcome of the subscription, issue/allotted price No. of equity Sr. Name of proposed shares Pre -issue Post-issue Category No. allottee proposed shareholding shareholding to be allotted No. of No. of shares shares WHITEOAK CAPITAL INDIA 1 AIF 0 3,02,065 3.87 OPPORTUNITIES 3,02,065 0 FUND AURUM RISING 2 AIF 0 0 1,64,165 2.10 INDIA FUND 1,64,165 WHITEOAK CAPITAL EQUITY TRUST - 1,31,332 3 AIF 0 0 1,31,332 1.68 WHITEOAK CAPITAL EQUITY FUND II ASHOK INDIA EQUITY 4 FPI 0 0 80,631 1.03 INVESTMENT 80,631 TRUST PLC WHITEOAK Mutual 5 CAPITAL MULTI 45,966 0 0 45,966 0.59 Fund CAP FUND INDIA ACORN 37,127 6 FPI 0 0 37,127 0.48 FUND LTD PERPETUITY HEALTH TO 36,116 7 AIF 27000 0.392 63,116 0.81 WEALTH (H2W) RISING FUND WHITEOAK 8 CAPITAL EQUITY AIF 26,266 0 0 26,266 0.34 FUND SOAR WEALTH 19,699 9 LLP 0 0 19,699 0.25 MANAGERS LLP SNEHAL BHUPENDRA SHAH 10 JOINT WITH Individual 19,699 679 0.010 20,378 0.26 SURABHI SNEHAL SHAH ASHOKA WHITEOAK 11 EMERGING FPI 13,579 0 0 13,579 0.17 MARKETS TRUST WHITEAOK CAPITAL PHARMA Mutual 12 5045 0.070 18,178 0.23 AND HEALTHCARE Fund 13,133 FUND 13 KISHORE MUNDRA Individual 9,849 0 0 9,849 0.13 NITIN JAIN, 6,566 14 DYMPAL NITIN Individual 0 0 6,566 0.08 JAIN WHITEOAK 6,566 CAPITAL Mutual 15 0 0 6,566 0.08 AGGRESSIVE Fund HYBRIDE FUND Total 9,12,759 32,724 0.472 9,45,483 12.11